Shares of Acorda Therapeutics (ACOR) plunge after a European regulatory committee recommends...

|About: Acorda Therapeutics, Inc. (ACOR)|By:, SA News Editor

Shares of Acorda Therapeutics (ACOR) plunge after a European regulatory committee recommends against approving Fampyra, the company's multiple sclerosis drug. ACOR -13.8% premarket.